CSIMarket Company Name, Ticker, Industry, else..
 
Elutia Inc   (NASDAQ: ELUT)
Other Ticker:  
 
 

ELUT's Market share relative to its competitors, as of Q1 2025

As of Q1 2025 (Revenue in Millions of $)

Date modified: 2025-06-14T14:04:56+00:00




 
COMPANY NAME REVENUES
12 Months Ending
Q1 2025		 MARKET SHARE
12 Months
Q1 2025		 MARKET SHARE
MRQ
Q1 2025		 MARKET SHARE
A Quarter Before
Q4 2024
Elutia Inc 23.32 0.60% 0.45 % 0.75 %
Integra Lifesciences Holdings Corp 1,624.31 41.90% 31.37% 52.20%
Novavax inc 1,254.96 32.37% 54.65% 10.41%
Organogenesis Holdings Inc 458.76 11.83% 7.11% 14.94%
Adaptimmune Therapeutics Plc 181.45 4.68% 0.60% 0.00%
Valneva Se 172.16 4.44% 4.44% 0.00%
Alector Inc 88.34 2.28% 0.30% 6.40%
Vaxart Inc 47.40 1.22% 1.71% 1.79%
Vir Biotechnology Inc 20.86 0.54% 0.25% 1.46%
Dyadic International Inc 3.55 0.09% 0.03% 0.10%
Mymetics Corporation 1.23 0.03% 0.00% 0.02%
Mink Therapeutics Inc 0.00 0.00% 0.00% 0.00%
Immunovant Inc 0.00 0.00% 0.00% 0.00%
SUBTOTAL 3,876.34 100% 1,219.80 100%



ELUT's Market share relative to its competitors, as of Q1 2025 within the Biotechnology & Pharmaceuticals Industry
As of Q1 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2025		 MARKET SHARE
12 Months Ending
Q4 2024		 MARKET SHARE
MRQ
Q1 2025		 MARKET SHARE

Q4 2024
Elutia Inc 1.30% 1.58% 0.73 % 2.27 %
Novavax inc 69.98% 45.47% 88.83% 31.70%
Adaptimmune Therapeutics Plc 10.12% 12.09% 0.97% 0.00%
Valneva Se 9.60% 26.97% 9.60% 26.97%
Alector Inc 4.93% 6.70% 0.49% 19.47%
Vaxart Inc 2.64% 1.91% 2.78% 5.45%
Vir Biotechnology Inc 1.16% 4.95% 0.40% 4.44%
Dyadic International Inc 0.20% 0.23% 0.05% 0.29%
Mymetics Corporation 0.07% 0.09% 0.01% 0.07%
Mink Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Immunovant Inc 0.00% 0.00% 0.00% 0.00%
SUBTOTAL 100% 100% 100% 100%



ELUT's Market share relative to its competitors, as of Q1 2025 within the Healthcare Sector
As of Q1 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2025		 MARKET SHARE
12 Months Ending
Q4 2024		 MARKET SHARE
MRQ
Q1 2025		 MARKET SHARE

Q4 2024
Elutia Inc 0.60% 0.66% 0.45 % 0.75 %
Integra Lifesciences Holdings Corp 41.90% 44.83% 31.37% 52.20%
Novavax inc 32.37% 18.99% 54.65% 10.41%
Organogenesis Holdings Inc 11.83% 13.42% 7.11% 14.94%
Adaptimmune Therapeutics Plc 4.68% 5.05% 0.60% 0.00%
Valneva Se 4.44% 11.26% 4.44% 11.26%
Alector Inc 2.28% 2.80% 0.30% 6.40%
Vaxart Inc 1.22% 0.80% 1.71% 1.79%
Vir Biotechnology Inc 0.54% 2.07% 0.25% 1.46%
Dyadic International Inc 0.09% 0.10% 0.03% 0.10%
Mymetics Corporation 0.03% 0.04% 0.00% 0.02%
Mink Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Immunovant Inc 0.00% 0.00% 0.00% 0.00%
SUBTOTAL 100% 100% 100% 100%



Note: Market share is calculated based on total revenue. To get a more accurate picture of Elutia Inc's market divisions, geographic dispersion, segments, products, and services, visit Elutia Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com